Cargando…
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
Many cancers overexpress one or more of the six human pro-survival BCL2 family proteins to evade apoptosis. To determine which BCL2 protein or proteins block apoptosis in different cancers, we computationally designed three-helix bundle protein inhibitors specific for each BCL2 pro-survival protein....
Autores principales: | Berger, Stephanie, Procko, Erik, Margineantu, Daciana, Lee, Erinna F, Shen, Betty W, Zelter, Alex, Silva, Daniel-Adriano, Chawla, Kusum, Herold, Marco J, Garnier, Jean-Marc, Johnson, Richard, MacCoss, Michael J, Lessene, Guillaume, Davis, Trisha N, Stayton, Patrick S, Stoddard, Barry L, Fairlie, W Douglas, Hockenbery, David M, Baker, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127641/ https://www.ncbi.nlm.nih.gov/pubmed/27805565 http://dx.doi.org/10.7554/eLife.20352 |
Ejemplares similares
-
Hsp90 Inhibition Decreases Mitochondrial Protein Turnover
por: Margineantu, Daciana H., et al.
Publicado: (2007) -
The Structural Biology of Bcl-x(L)
por: Lee, Erinna F., et al.
Publicado: (2019) -
Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
por: Fairlie, W. Douglas, et al.
Publicado: (2021) -
Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer
por: Lee, Erinna F., et al.
Publicado: (2021) -
Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
por: Fairlie, Walter Douglas, et al.
Publicado: (2021)